Clinical Trial Update: BEACON - ABC in Recurrent Platinum Resistant HGSOC [Phase 2]

View source ↗

Summary

Phase 2 trial update for BEACON program in recurrent platinum-resistant high-grade serous ovarian cancer (HGSOC).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fallopian Tube Cancer
• Ovarian Cancer
• Peritoneal Cancer

Drugs mentioned

• BEACON

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Ovarian Cancer, Fallopian Tube Cancer | Phase 2 | Status: UNKNOWN